1-4 of 4
Ingebjørg Seljeflot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study

Maryam Saeed, German Tapia, Inger Ariansen, Lars C. Stene, Ingebjørg Seljeflot, Grethe S. Tell, Torild Skrivarhaug, Geir Joner
Journal: Diabetes Care
Diabetes Care 2021;44(3):810–816
https://doi.org/10.2337/dc20-1712
Published: 06 January 2021
View article titled, Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study
Open the PDF for Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study in another window
Journal Articles

Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097

David A. Fraser, PHD, Lien M. Diep, MSC, Inger Anette Hovden, MD, PHD, Kristian B. Nilsen, MD, PHD, Kari Anne Sveen, MD, Ingebjørg Seljeflot, PHD, Kristian F. Hanssen, MD, PHD
Journal: Diabetes Care
Diabetes Care 2012;35(11):e80
https://doi.org/10.2337/dc12-1124
Published: 13 October 2012
View article titled, Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
Open the PDF for Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097 in another window
Journal Articles

The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-month, double-blind, randomized, placebo-controlled trial

David A. Fraser, PHD, Lien M. Diep, MSC, Inger Anette Hovden, MD, Kristian B. Nilsen, MD, Kari Anne Sveen, MD, Ingebjørg Seljeflot, PHD, Kristian F. Hanssen, MD
Journal: Diabetes Care
Diabetes Care 2012;35(5):1095–1097
https://doi.org/10.2337/dc11-1895
Published: 11 April 2012
View article titled, The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: <subtitle>A 24-month, double-blind, randomized, placebo-controlled trial</subtitle>
Open the PDF for The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: <subtitle>A 24-month, double-blind, randomized, placebo-controlled trial</subtitle> in another window
Includes: Supplementary data
Journal Articles

Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome: Synergistic effect of inflammation and hyperglycemia

Marius Trøseid, MD, Ingebjørg Seljeflot, PHD, Elsa M. Hjerkinn, MD, PHD, Harald Arnesen, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(3):486–492
https://doi.org/10.2337/dc08-1710
Published: 01 March 2009
View article titled, Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome: <subtitle>Synergistic effect of inflammation and hyperglycemia</subtitle>
Open the PDF for Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome: <subtitle>Synergistic effect of inflammation and hyperglycemia</subtitle> in another window
Includes: Supplementary data